Assessment of regeneration in meniscal lesions by use of mesenchymal stem cells derived from equine bone marrow and adipose tissue.
González-Fernández ML., Pérez-Castrillo S., Sánchez-Lázaro JA., Prieto-Fernández JG., López-González ME., Lobato-Pérez S.
Animal Study on Meniscus Injury, published in Am J Vet Res (2016) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Am J Vet Res (2016)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 27347833
- DOI
- 10.2460/ajvr.77.7.779
Abstract (original English)
OBJECTIVE To assess the ability to regenerate an equine meniscus by use of a collagen repair patch (scaffold) seeded with mesenchymal stem cells (MSCs) derived from bone marrow (BM) or adipose tissue (AT). SAMPLE 6 female Hispano-Breton horses between 4 and 7 years of age; MSCs from BM and AT were obtained for the in vitro experiment, and the horses were subsequently used for the in vivo experiment. PROCEDURES Similarities and differences between MSCs derived from BM or AT were investigated in vitro by use of cell culture. In vivo assessment involved use of a meniscus defect and implantation on a scaffold. Horses were allocated into 2 groups. In one group, defects in the medial meniscus were treated with MSCs derived from BM, whereas in the other group, defects were treated with MSCs derived from AT. Defects were created in the contralateral stifle joint but were not treated (control samples). RESULTS Both types of MSCs had universal stem cell characteristics. For in vivo testing, at 12 months after treatment, treated defects were regenerated with fibrocartilaginous tissue, whereas untreated defects were partially repaired or not repaired. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that MSCs derived from AT could be a good alternative to MSCs derived from BM for use in regenerative treatments. Results also were promising for a stem cell-based implant for use in regene
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Optimizing Meniscus Allograft Transplantation - Reducing Extrusion and Restoring Joint Loading Mechanics: A Systematic Review
Systematic Review on Osteoarthritis, Meniscus Injury, published in Curr Rev Musculoskelet Med (2026) — summary generated from the PubMed abstract.
- 2026
Curr Rev Musculoskelet Med - Level ASystematic ReviewEurope PMC
Emerging biologic augmentation strategies for meniscal repair: a systematic review
Systematic Review with a reported sample of 18 on Meniscus Injury, Chronic Wound, published in BMC Musculoskelet Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 18
BMC Musculoskelet Disord7 citations - Level ASystematic ReviewEurope PMC
Osteoarthritis After Anterior Cruciate Ligament Reconstruction: A Systematic Review of Contributing Factors and Potential Treatments
Systematic Review on Osteoarthritis, Meniscus Injury, Ligament Injury, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus1 citations - Level ASystematic ReviewPubMed
Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.
Systematic Review on Osteoarthritis, Meniscus Injury, published in Knee Surg Sports Traumatol Arthrosc (2022) — summary generated from the PubMed abstract.
- 2022
Knee Surg Sports Traumatol Arthrosc40 citations - Level ASystematic ReviewPubMed
Cell-based therapy in soft tissue sports injuries of the knee: a systematic review.
Systematic Review with a reported sample of 9 on Osteoarthritis, Meniscus Injury, Tendon Injury, Ligament Injury, published in Expert Opin Biol Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 9
Expert Opin Biol Ther10 citations - Level ASystematic ReviewPubMed
Stem cells application in meniscal tears: a systematic review of pre-clinical and clinical evidence.
Systematic Review on Meniscus Injury, published in Eur Rev Med Pharmacol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Eur Rev Med Pharmacol Sci